DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
DALS was delisted on the 28th of July, 2023.
47 hedge funds and large institutions have $166M invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 6 closing their positions.
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
10% more capital invested
Capital invested by funds: $151M → $166M (+$14.7M)
9% more funds holding
Funds holding: 43 → 47 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIM
Cowen Investment Management
New York
|
+$6.89M |
| 2 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$2.44M |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$1.48M |
| 4 |
SIA
Schechter Investment Advisors
Birmingham,
Michigan
|
+$1.29M |
| 5 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$1.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIA
RP Investment Advisors
Toronto,
Ontario, Canada
|
-$4.04M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$2.2M |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.06M |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$881K |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$487K |
DALS Hedge Fund Activity: Q4 2022 in Review
47 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q4 2022, worth a combined $166M — up 9.7% from $151M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new DALS positions and 6 closed out — a net gain of 4 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was Cowen Investment Management, adding an estimated $6.89M. The largest seller was RP Investment Advisors, exiting entirely with an estimated $4.04M sold.
- 47 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q4 2022, up from 43 in Q3 2022.
- Funds reported $166M of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q4 2022, up 9.7% quarter-over-quarter.
- 10 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q4 2022 and 6 closed out, a net change of +4 holders.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock buyer in Q4 2022 was Cowen Investment Management, an estimated $6.89M added.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q4 2022 was RP Investment Advisors, an estimated $4.04M sold.
Based on aggregated 13F filings for Q4 2022.